期刊文献+

益气活络方对2型糖尿病早期肾病患者的临床疗效

Yiqi Adjustable on the Elinical Efficacy of Early Type 2 Diabetic Nephropathy Patients
下载PDF
导出
摘要 目的探讨益气活络方对2型糖尿病早期肾病患者的治疗效果。方法该院2015年2月—2016年2月将收治的60例2型糖尿病早期肾病患者计算机随机分为两组,对照组选择洛丁新进行治疗,观察组患者在对照组的基础上,采用益气活络方进行治疗。结果观察组患者总有效率与对照组患者相比有明显优势(P<0.05)。结论益气活络方对2型糖尿病早期肾病患者的效果明显,无不良反应,安全性高。 Objective to study the yiqi adjustable side effect on the treatment of patients with early type 2 diabetic nephropathy. Methods Early of 60 patients admitted in our hospital will be in patients with type 2 diabetic nephropathy(February 2014 to February 2015) computer were randomly divided into two groups, control group choose los Ding Xin treatment, observation group of patients in the control group, on the basis of using yiqi active treatment. Results The total effective rate observation group of patients compared with control group patients have obvious advantages, P〈0.05). Conclusion Yiqi adjustable side effect on early type 2 diabetic nephropathy patients, no adverse reaction, high safety.
作者 杨黎
出处 《糖尿病新世界》 2016年第14期37-38,共2页 Diabetes New World Magazine
关键词 益气活络方 2型糖尿病早期肾病患者 临床疗效 Yiqi adjustable square Early in patients with type 2 diabetic nephropathy Clinical curative effect
  • 相关文献

参考文献5

二级参考文献43

  • 1刘玉倩,宁均,刘青.2型糖尿病肾病患者血清中骨形态发生蛋白-7及转化生长因子-β1水平的变化及意义[J].中国老年学杂志,2014,34(8):2030-2032. 被引量:4
  • 2徐幼桥,李伟求,江时森,宫剑滨,陈一天,刘挺松.老年2型糖尿病患者急性心肌梗死早期血糖变异对冠状动脉病变的影响[J].东南国防医药,2013,15(2):122-124. 被引量:5
  • 3杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1155
  • 4Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis [ J ]. Kidney Int, 2006, 69(12) :2131.
  • 5Wu Y, Dong J, Yuan L, et al. Nephrin and podocin loss is prevented by myeophenolate mofetil in early experimental diabetic nephropathy [ J 1. Cytokine, 2008,44 ( 1 ) : 85.
  • 6Nakanishi N,Okamoto M,Yoshida H,et al. Serum uric acidand risk for development of hypertension and impaired fast-ing glucose or Type II diabetes in Japanese male officeworkers[J]. Eur J Epidemiol, 2003,18(6); 523-530.
  • 7Feig DI,Kang DH,Johnson RJ. Uric acid and cardiovascularrisk[J]. N Engl J Med,2008,359(17):1811-1821.
  • 8Ben-Dov IZ,Kark JD. Serum uric acid is a GFR-indepen-dent long-term predictor of acute and chronic renal insuffi-ciency : the Jerusalem Lipid Research Clinic cohort study[J].Nephrol Dial Transplant, 2011,26( 8 ) : 2558-2566.
  • 9Collins AJ,Foley RN,Chavers B,et al. United States RenalData System 2011 Annual Data Report : Atlas of chronickidney disease & end -stage renal disease in the UnitedStates [J]. Am J Kidney Dis,2012,59(1 Suppl l):A7,el-420.
  • 10Collins AJ,Foley RN,Herzog C,et al. US Renal Data Sys-tem 2012 Annual Data Report [J]. Am J Kidney Dis,2013,61(1 Suppl 1):A7, el-476.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部